The historical rank and industry rank for Foghorn Therapeutics's FCF Margin % or its related term are showing as below:
FHTX'
s FCF Margin % Range Over the Past 10 Years
Min: -11039.3 Med: -2205.13 Max: 1000.63
Current: -345.06
During the past 6 years, the highest FCF Margin % of Foghorn Therapeutics was 1000.63%. The lowest was -11039.30%. And the median was -2205.13%.
FHTX's FCF Margin % is ranked worse than 61.32% of 1047
companies
in the Biotechnology industry
Industry Median: -145.04
vs FHTX: -345.06
Foghorn Therapeutics FCF Margin % Historical Data
The historical data trend for Foghorn Therapeutics's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Foghorn Therapeutics's FCF Margin %
For the Biotechnology subindustry, Foghorn Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Foghorn Therapeutics's FCF Margin % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Foghorn Therapeutics's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Foghorn Therapeutics's FCF Margin % falls into.
Foghorn Therapeutics FCF Margin % Calculation
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
Foghorn Therapeutics's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Foghorn Therapeutics FCF Margin % Related Terms
Thank you for viewing the detailed overview of Foghorn Therapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Foghorn Therapeutics (Foghorn Therapeutics) Business Description
Foghorn Therapeutics Inc is engaged in the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Its proprietary Gene Traffic Control platform gives an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing it to identify, validate and potentially drug targets within the system. The company is developing FHD-286, a selective, allosteric ATPase inhibitor, and FHD-609, a protein degrader, to treat hematologic cancers and solid tumors.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FHTX has been successfully added to your 